Nadia Altomare, Julie Barnes, and Chris Poole
Abcodia has appointed three new members to its leadership team. Nadia Altomare has been named CEO, Julie Barnes has been appointed chief scientific officer, and Chris Poole has been named CFO. Altomare currently serves as president of Abcodia's US subsidiary, and previously served as vice president and manager of Life Technologies (before it was acquired by Thermo Fisher Scientific). Barnes is the founding CEO of Abcodia. Poole most recently served as CFO for Sinwave, and previously served as finance director for Enecsys Limited. Altomare and Barnes are both current members of the company's board of directors and Poole will join the board alongside his new position.
Transplant Genomics Scientific Advisory Board Expansion
Transplant Genomics has appointed four new members to its scientific advisory board: Bruce McManus, Goran Klintmalm, Parmjeet Ranhawa, and Bruce Kaplan.
- McManus is a professor in the department of pathology and laboratory Medicine at the University of British Columbia. He also serves as the CEO for the Centre of Excellence for Prevention of Organ Failure, co-director of the Institute of Heart + Lung Health, and as immediate-past director of the UBC James Hogg Research Centre/Centre for Heart Lung Innovation.
- Klintmalm is the chairman and chief of the Simmons Transplant Institute at Baylor University Medical Center and director of the Dallas Liver Transplant Program.
- Ranhawa is a professor of pathology and member of the Division of Transplant Pathology at the University of Pittsburgh Medical Center. He is also on the Editorial Board of The American Journal of Kidney Diseases.
- Kaplan is a professor of medicine and professor of surgery and pharmacology, medical director of the Abdominal Transplant Program, and section chief of nephrology at the University of Arizona College of Medicine.
Genomics plc has tapped Sekar Kathiresan, a clinical cardiologist and human geneticist, to chair its newly-formed Scientific Advisory Board. Kathiresan is the director of preventive cardiology at Massachusetts General Hospital. He is also an associate member of the Broad Institute’s Medical and Population Genetics program and an associate professor of medicine at Harvard Medical School. Previously, he was MGH's chief resident in internal medicine. In 2015, he was selected by the National Institutes of Health to join a panel of experts formed to steer President Obama's Precision Medicine Initiative.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.